Investment bank Needham & Company said Tuesday that it has hired Mike Matson as a senior research analyst. In his new role, Matson will be covering medical technologies & diagnostics and be based in the company’s New York office. Previously, Matson worked at Mizuho Securities and Wells Fargo Securities.
NEW YORK–(BUSINESS WIRE)–Needham & Company, LLC, a privately held, full-service investment bank, announced today that Mike Matson recently joined the Firm as a Senior Research Analyst covering Medical Technologies & Diagnostics. He will be based in the Firm’s New York office.
Prior to joining Needham, Mike spent nine years covering the medical supplies and devices industry for Mizuho Securities and Wells Fargo Securities. He also previously worked in the medical device industry for Stryker’s Orthopedics and Endoscopy divisions in marketing and product development. Mike was ranked first for earnings estimating in the medical device industry in the 2013 FT/StarMine World’s Top Analysts survey, second for stock picking in the medical device industry in the 2008 FT/StarMine World’s Top Analysts survey, and fourth in the medical device industry for stock picking in the 2007 Wall Street Journal’s Best on the Street.
“Mike’s expertise will add another important dimension to our Healthcare Research Group,” said Tom Maloney, Director of Research. “We think medical device and diagnostics companies are an important growth area in the healthcare space, and Mike’s outstanding reputation gives us increased visibility and credibility in the space.” To date, Mike has rolled out coverage on several companies including C.R. Bard, Inc. (BCR), CONMED Corporation (CNMD), Covidien plc (COV), MAKO Surgical Corp. (MAKO), Nuvasive, Inc. (NUVA), ResMed Inc. (RMD), Stryker Corp. (SYK), Wright Medical Group, Inc. (WMGI) and Zimmer Holdings, Inc. (ZMH).
Mr. Matson has a B.S. in Mechanical Engineering from North Carolina State University with a minor in Economics and a M.B.A. from Duke University’s Fuqua School of Business with a concentration in Health Sector Management. Mike is a CFA charterholder and holds a medical device patent (U.S. patent 6,919,914).
About Needham & Company, LLC
Needham & Company, LLC, a wholly owned subsidiary of The Needham Group, Inc., is a privately held, full-service investment bank that has focused exclusively on growth companies since it was founded 28 years ago. It concentrates on private companies and on public companies that have market capitalizations of up to $5 billion, and provides its clients with the resources to achieve their financing and strategic objectives. The Firm has capital raising expertise in IPOs, follow-on public equity offerings, confidentially marketed equity offerings, and private placements and in mergers & acquisitions and corporate & venture services (including share repurchases). In addition to investment banking, Needham’s activities include institutional sales and trading, and asset management. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 325 companies in clean technology and industrial growth, communications and enterprise infrastructure, consumer, healthcare, semiconductors and semiconductor equipment, and software. The Firm is headquartered in New York City with offices in Boston, MA; Chicago, IL; Menlo Park, CA; and San Francisco, CA. Needham & Company, LLC is a member of FINRA & SIPC. For more information, please visit www.needhamco.com.